AUD294.45
0.37% yesterday
Australia, Nov 15, 06:00 am CET
ISIN
AU000000COH5
Symbol
COH
Sector

Cochlear Target price 2024 - Analyst rating & recommendation

Cochlear Classifications & Recommendation:

Buy
25%
Hold
56%
Sell
19%

Cochlear Price Target

Target Price AUD302.09
Price AUD294.94
Potential
Number of Estimates 14
14 Analysts have issued a price target Cochlear 2025 . The average Cochlear target price is AUD302.09. This is higher than the current stock price. The highest price target is
AUD345.00 16.97%
register free of charge
, the lowest is
AUD260.00 11.85%
register free of charge
.
A rating was issued by 16 analysts: 4 Analysts recommend Cochlear to buy, 9 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cochlear stock has an average upside potential 2025 of . Most analysts recommend the Cochlear stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Billion AUD 2.26 2.46
15.47% 8.98%
EBITDA Margin 26.85% 26.13%
6.46% 2.69%
Net Margin 15.74% 17.09%
3.09% 8.59%

14 Analysts have issued a sales forecast Cochlear 2025 . The average Cochlear sales estimate is

AUD2.5b
Unlock
. This is
8.98% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD2.5b 10.23%
Unlock
, the lowest is
AUD2.4b 6.59%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD2.3b 15.47%
2025
AUD2.5b 8.98%
Unlock
2026
AUD2.7b 8.58%
Unlock
2027
AUD2.9b 9.03%
Unlock
2028
AUD3.1b 7.65%
Unlock
2029
AUD3.4b 9.18%
Unlock

14 Analysts have issued an Cochlear EBITDA forecast 2025. The average Cochlear EBITDA estimate is

AUD643m
Unlock
. This is
6.06% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD668m 10.16%
Unlock
, the lowest is
AUD612m 0.95%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD606m 22.93%
2025
AUD643m 6.06%
Unlock
2026
AUD709m 10.24%
Unlock
2027
AUD797m 12.38%
Unlock
2028
AUD865m 8.59%
Unlock
2029
AUD999m 15.45%
Unlock

EBITDA Margin

2024 26.85% 6.46%
2025
26.13% 2.69%
Unlock
2026
26.53% 1.53%
Unlock
2027
27.35% 3.09%
Unlock
2028
27.59% 0.88%
Unlock
2029
29.17% 5.73%
Unlock

9 Cochlear Analysts have issued a net profit forecast 2025. The average Cochlear net profit estimate is

AUD421m
Unlock
. This is
18.38% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD427m 20.04%
Unlock
, the lowest is
AUD416m 16.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD355m 19.04%
2025
AUD421m 18.38%
Unlock
2026
AUD463m 10.14%
Unlock
2027
AUD524m 13.05%
Unlock
2028
AUD599m 14.29%
Unlock
2029
AUD713m 19.07%
Unlock

Net Margin

2024 15.74% 3.09%
2025
17.09% 8.59%
Unlock
2026
17.34% 1.46%
Unlock
2027
17.98% 3.69%
Unlock
2028
19.09% 6.17%
Unlock
2029
20.82% 9.06%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD 5.44 6.44
19.04% 18.38%
P/E 45.80
EV/Sales 7.72

9 Analysts have issued a Cochlear forecast for earnings per share. The average Cochlear <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

AUD6.44
Unlock
. This is
18.38% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
AUD6.53 20.04%
Unlock
, the lowest is
AUD6.36 16.91%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD5.44 19.04%
2025
AUD6.44 18.38%
Unlock
2026
AUD7.09 10.09%
Unlock
2027
AUD8.02 13.12%
Unlock
2028
AUD9.16 14.21%
Unlock
2029
AUD10.91 19.10%
Unlock

P/E ratio

Current 54.17 1.95%
2025
45.80 15.45%
Unlock
2026
41.58 9.21%
Unlock
2027
36.79 11.52%
Unlock
2028
32.19 12.50%
Unlock
2029
27.03 16.03%
Unlock

Based on analysts' sales estimates for 2025, the Cochlear stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.41 1.45%
2025
7.72 8.26%
Unlock
2026
7.11 7.91%
Unlock
2027
6.52 8.28%
Unlock
2028
6.05 7.10%
Unlock
2029
5.54 8.41%
Unlock

P/S ratio

Current 8.53 0.72%
2025
7.82 8.24%
Unlock
2026
7.21 7.90%
Unlock
2027
6.61 8.28%
Unlock
2028
6.14 7.10%
Unlock
2029
5.62 8.41%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today